Aura231 发表于 2025-3-23 11:42:44
Book 2021care options, have to a great extent contributed to increased workloads for healthcare professionals and put them under pressure to prioritize their work. This has led to the rationing of care, i.e., to decision-making processes on the allocation of scarce resources, especially human resources, and不透明性 发表于 2025-3-23 14:06:12
Introduction, there are constraints and restrictions in the delivery of care and interestingly in his conclusive statements he points out the “limits of caring of others” introducing to the idea of care rationing. The term rationing is used to demonstrate the allocation of scarce resources between competing healBURSA 发表于 2025-3-23 20:18:36
http://reply.papertrans.cn/47/4625/462441/462441_13.pngAbsenteeism 发表于 2025-3-24 01:06:41
http://reply.papertrans.cn/47/4625/462441/462441_14.png增强 发表于 2025-3-24 03:49:40
Patient Safety in Nurse Education,curriculum patient safety content is largely implicit. In this chapter we explore how a more explicit focus on patient safety education in the curriculum would equip nurses with the knowledge, skills, attitudes and behaviours to advance the patient safety agenda generally, and more specifically to g织布机 发表于 2025-3-24 10:26:05
Good Management and Clinical Leadership: Supporting Quality Patient Care,ons in care, auditing of practice or complaints related to the rationing of nursing care. Rationing of nursing care refers to the necessary nursing-related activities that nurses omitted or did not perform due to limited time, staffing level, or lack of skills..In this section, we will highlight theviolate 发表于 2025-3-24 14:11:24
working understanding of pharmacokinetics and pharmacodynamics, modeling, pharmacometric analyses, and/or the drug development and regulatory processes.978-1-4614-2784-1978-1-4419-7415-0Series ISSN 2210-7371 Series E-ISSN 2210-738XJECT 发表于 2025-3-24 16:02:51
Evridiki Papastavrou,Riitta Suhonen working understanding of pharmacokinetics and pharmacodynamics, modeling, pharmacometric analyses, and/or the drug development and regulatory processes.978-1-4614-2784-1978-1-4419-7415-0Series ISSN 2210-7371 Series E-ISSN 2210-738X加入 发表于 2025-3-24 22:05:22
Terry Jones,Anat Drach-Zahavy,Walter Sermeus,Eileen Willis,Renata Zelenikova working understanding of pharmacokinetics and pharmacodynamics, modeling, pharmacometric analyses, and/or the drug development and regulatory processes.978-1-4614-2784-1978-1-4419-7415-0Series ISSN 2210-7371 Series E-ISSN 2210-738X推测 发表于 2025-3-25 02:54:02
Michael Igoumenidis,Evridiki Papastavrou working understanding of pharmacokinetics and pharmacodynamics, modeling, pharmacometric analyses, and/or the drug development and regulatory processes.978-1-4614-2784-1978-1-4419-7415-0Series ISSN 2210-7371 Series E-ISSN 2210-738X